GlassScriptPhysician profile
Colleen H Boyd
NPI 1740524768
$21,343.14
in general payments reported to CMS, 2019-2025
65 companies · $6,063 in 2025
The $6,063 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $3,616 · 2023: $5,632 · 2024: $5,722 · 2025: $6,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,417.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $2,977.06 | 2022-2025 | Nuplazid |
| Abbvie INC. | $1,899.12 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $1,650.02 | 2022-2025 | |
| Ucb, INC. | $1,277.58 | 2022-2025 | Rystiggo, Briviact, Nayzilam |
| Tg Therapeutics, INC. | $987.57 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $972.00 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $736.03 | 2022-2025 | Ingrezza, Ongentys |
| Emd Serono, INC. | $620.13 | 2022-2025 | Mavenclad, Mavenclad |
| Lilly USA, LLC | $611.47 | 2021-2025 | Kisunla, Amyvid, Emgality |
| Pfizer INC. | $567.79 | 2023-2025 | |
| Lundbeck LLC | $531.74 | 2022-2025 | Vyepti, Rexulti |
| Eisai INC. | $518.16 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $435.31 | 2022-2025 | Crexont, Lyvispah, Rytary |
| Argenx US, INC. | $427.95 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Janssen Pharmaceuticals, INC | $394.11 | 2022-2025 | Spravato |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $378.65 | 2022-2025 | Zeposia |
| Alexion Pharmaceuticals, INC. | $370.64 | 2022-2025 | Ultomiris, Soliris |
| Kyowa Kirin, INC. | $352.97 | 2022-2024 | Nourianz |
| Sk Life Science, INC. | $313.71 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $308.40 | 2023-2025 | Rexulti, Nuedexta |
| Biohaven Pharmaceutical Holding Company LTD. | $305.32 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $295.07 | 2023-2025 | Hyqvia |
| Genzyme Corporation | $285.24 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $279.45 | 2022-2025 | Cobenfy, Zeposia |
| Merz Pharmaceuticals, LLC | $277.97 | 2022-2025 | Inbrija, Xeomin, Ampyra |
| Astrazeneca Pharmaceuticals LP | $248.14 | 2021-2025 | Wainua |
| Amgen INC. | $238.03 | 2022-2025 | Uplizna, Aimovig |
| Biogen, INC. | $227.93 | 2022-2025 | Vumerity, Tysabri, Leqembi |
| Averitas Pharma INC. | $226.53 | 2024-2025 | Qutenza |
| Axsome Therapeutics, INC. | $207.45 | 2023-2025 | Symbravo, Sunosi, Auvelity |
| Genentech USA, INC. | $205.76 | 2021-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Banner Life Sciences, LLC | $186.46 | 2022-2024 | |
| Vanda Pharmaceuticals INC. | $185.63 | 2022-2025 | Ponvory, Hetlioz |
| Jazz Pharmaceuticals INC. | $153.18 | 2024-2025 | |
| Amylyx Pharmaceuticals, INC. | $115.61 | 2023-2024 | Relyvrio |
| Esperion Therapeutics, INC. | $111.73 | 2021 | |
| Acorda Therapeutics, INC | $110.81 | 2022-2024 | Inbrija |
| Sumitomo Pharma America, INC. | $102.23 | 2023 | Aptiom |
| Catalyst Pharmaceuticals, INC. | $99.45 | 2023-2025 | Fycompa |
| Tanabe Pharma America, INC. | $99.06 | 2022-2024 | |
| Medtronic, INC. | $92.74 | 2022-2025 | Intellis Adaptivestim |
| Mdd US Operations, LLC | $82.13 | 2022-2023 | Xadago, Apokyn, Myobloc |
| Impel Pharmaceuticals INC. | $77.32 | 2023 | Trudhesa |
| Scilex Pharmaceuticals INC. | $67.93 | 2023-2024 | Ztlido |
| Ultragenyx Pharmaceutical INC. | $65.98 | 2023-2025 | Dojolvi |
| Avanir Pharmaceuticals, INC. | $58.33 | 2022 | |
| Hospira, INC. | $49.17 | 2022 | |
| Idorsia Pharmaceuticals US INC | $46.77 | 2023-2024 | Quviviq |
| Alnylam Pharmaceuticals INC. | $44.13 | 2022-2023 | Onpattro |
| Abbott Laboratories | $43.94 | 2023-2025 | Amplatzer Talisman, Infinity |
| Grifols USA, LLC | $42.95 | 2024-2025 | Gamunex-C |
| Xeris Pharmaceuticals, INC. | $40.42 | 2024-2025 | Keveyis |
| Avion Pharmaceuticals | $34.39 | 2021-2023 | Dhivy |
| Sunovion Pharmaceuticals INC. | $34.26 | 2022 | |
| Boston Scientific Corporation | $31.37 | 2024 | Watchman Flx |
| Csl Behring | $28.82 | 2024 | Hizentra |
| Ani Pharmaceuticals, INC. | $28.47 | 2025 | Purified Cortrophin Gel |
| Currax Pharmaceuticals LLC | $28.30 | 2022-2023 | Onzetra Xsail |
| Neurelis, INC. | $24.72 | 2025 | Valtoco |
| Hologic Sales and Service, LLC | $24.50 | 2021 | |
| Noctrix Health, INC. | $22.96 | 2024 | Nidra |
| Mallinckrodt Hospital Products INC. | $22.63 | 2025 | Acthar |
| Ipsen Biopharmaceuticals, INC | $22.45 | 2022 | |
| Insightec,INC | $19.08 | 2025 | Exablate |
| Cala Health, INC. | $17.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.